Latuda Tablet, Film Coated
Product Images NDC 63402-306

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Latuda (NDC 63402-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sumitomo Pharma America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lat01 0042 01)

Chemical structure of lurasidone hydrochloride, showing the detailed molecular arrangement including multiple rings and functional groups typical of this active pharmaceutical ingredient.*

FDA Label Image

Figure 1 (Lat01 0042 02)

A pharmacokinetic chart showing fold changes and 90% confidence intervals in Cmax and AUC of lurasidone hydrochloride when co-administered with interacting drugs classified as strong CYP3A4 inhibitors, moderate CYP3A4 inhibitors, and strong CYP3A4 inducers. The x-axis represents the change relative to lurasidone alone, ranging from -4 to +4.*

FDA Label Image

Figure 2 (Lat01 0042 03)

A forest plot chart illustrating the fold change and 90% confidence interval in pharmacokinetic parameters (Cmax, AUC, Ctrough) for several drugs when administered with another interactive drug. The drugs shown include digoxin, midazolam, ethinyl estradiol, norelgestromin, and lithium, with the x-axis representing change relative to the interactive drug alone.*

FDA Label Image

Figure 3 (Lat01 0042 04)

Pharmacokinetic chart showing fold change and 90% confidence intervals for lurasidone hydrochloride. It compares Cmax and AUC values relative to reference for different levels of renal and hepatic impairment (mild, moderate, severe), as well as population subgroups by gender, and race (Asian), illustrating variation in drug exposure.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Latuda 20 mg (lurasidone HCl) film coated tablets label showing 30 tablets per container. The label includes dosage form and strength, dispensing information directing to a medication guide at latuda.com, and manufacturer details for Sunovion Pharmaceuticals Inc. The product is made in Japan and marked Rx only.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Latuda 40 mg film-coated tablets label showing the product name, strength, dosage form, and quantity of 30 tablets. The label includes the active ingredient lurasidone hydrochloride, barcode, manufacturer Sunovion Pharmaceuticals Inc, and storage instructions. A dispenser warning advises providing the Medication Guide with each dispensation.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Latuda 60 mg film-coated tablets label showing lurasidone hydrochloride as the active ingredient. The label indicates a package size of 30 tablets, with directions to see the package insert for dosage and use. It includes storage instructions and is manufactured by Sunovion Pharmaceuticals Inc., Marlborough, MA, made in Japan, with a 2017 copyright.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Label for Latuda 60 mg tablets, a film-coated oral tablet containing lurasidone hydrochloride. The label indicates a package of 90 tablets, with NDC 63402-306-90. It includes dispensing instructions, storage conditions, and is manufactured for Sunovion Pharmaceuticals Inc. in Marlborough, MA by Sumitomo Pharma America, Inc.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Label for Latuda (lurasidone HCl) 60 mg film-coated tablets, supplied in a bottle of 500 tablets. The label includes dispensing instructions, manufacturer information (Sunovion Pharmaceuticals Inc. and Sumitomo Pharma America, Inc.), and storage conditions. The label prominently displays the product name, strength, dosage form, and the requirement to provide the Medication Guide with each dispensation.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Packaging label for Latuda 60 mg film-coated tablets (lurasidone HCl), an oral prescription drug by Sunovion Pharmaceuticals. The label indicates a 7-tablet supply with a day-by-day layout for dosing. It includes storage instructions, prescription-only status, and a professional sample notice. The label displays the tablet imprint 'L 60' and provides information for patient dispensing and safety warnings.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL – 60 mg Carton)

Packaging label for Latuda 60 mg tablets, containing lurasidone hydrochloride. The label shows a film-coated tablet dosage form, with 28 tablets per carton (4 cards, 7 tablets each). The labeler is Sunovion Pharmaceuticals Inc. The carton includes storage instructions, usage notes, and a barcode.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL – 60 mg Blister)

This image shows multiple identical labels for Latuda 60 mg tablets containing lurasidone hydrochloride. Each label includes the product name, strength, dosage form as tablet, a barcode, and space for expiration and lot number. The labels indicate Sunovion Pharmaceuticals Inc. as the manufacturer.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Packaging label for Latuda 60 mg film-coated tablets, containing lurasidone hydrochloride. The label indicates a package size of 100 tablets (10 cards of 10 tablets each). Manufactured for Sunovion Pharmaceuticals, the label includes dosage information, storage instructions, and a barcode. The label is predominantly white with yellow and black text.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Latuda 80 mg (lurasidone hydrochloride) tablets label for a 30-tablet packaging. The label includes dosage form as film-coated tablets, storage instructions, dispensing guidance, NDC 63402-308-30, and manufacturer information for Sunovion Pharmaceuticals Inc., made in Japan.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Label for Latuda (lurasidone HCl) tablets 120 mg oral film-coated tablets. The package contains 30 tablets. The label includes dosage information, storage instructions, and a barcode. The product is manufactured for Sunovion Pharmaceuticals Inc., made in Japan, and distributed in Marlborough, MA, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.